THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

associated system failures simply because neither physicians nor individuals have all of the information required to make suitable judgments of solution quality and lawful tort remedies are sluggish, inefficient, and extremely high priced. The adjustments into the CGMP regulation will require manufacturers to extend [Web page 52644] their quality m